It’s Tip off Season for the Harlem Globetrotters Tickets Go on Sale Today for the Harlem Globetrotters 2025 World Tour
The World-Famous, Harlem Globetrotters are coming to a city near you! The legendary and awe-inspiring basketball team have announced their upcoming 2025 World Tour beginning Thursday, December 26, 2024 with global tickets on sale today, it was announced by Keith Dawkins, President, Harlem Globetrotters & Herschend Entertainment Studios.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240916952134/en/
(L-R) Rock 'Wham' Middleton, Donte 'Hammer' Harrison (Photo: Business Wire)
“The Harlem Globetrotters continue to be celebrated as ambassadors of goodwill, combining sportsmanship and entertainment while bringing joy to families all over the world,” said Dawkins. “Our global tour remains a core part of our business but we’ve also been able to expand the brand with new widely distributed content, new strategic partners, unique merchandise offerings, elevated social extensions and deeper fan experiences. This increased activity has us well positioned for our 100-year anniversary in 2026 and beyond.”
Revered for their exceptional athleticism, basketball wizardry, and heartwarming interactions with fans of all ages, they will captivate audiences with never-before-seen tricks, fan engagement, and heartwarming moments that have become synonymous with the Harlem Globetrotters. Tour schedule and ticket purchase can be found HERE and directly on the Harlem Globetrotters website.
The North American leg of the tour, sponsored by Jersey Mike’s Subs, begins Thursday, December 26 with the tour continuing throughout spring 2025. International markets such as France, United Kingdom, Italy, Germany, Spain, Switzerland, Belgium, Netherlands, Mexico and across Asia are just a few of the many locations the Harlem Globetrotters will be touring in, winter 2025 and running through the remainder of the year. Spalding continues its role as the official global ball partner of the Harlem Globetrotters.
Citi cardmembers will have access to pre-sale tickets in select markets beginning 10:00 a.m. ET Tuesday, September 17th - Sunday, September 29th 10:00 p.m. ET through the Citi Entertainment program. For complete presale details visit www.citientertainment.com
The Harlem Globetrotters Pre-Sale Begins Monday, September 23rd. Fans can request an early access code now at HarlemGlobetrotters.com.
ABOUT THE WORLD-FAMOUS HARLEM GLOBETROTTERS™ / HERSCHEND ENTERTAINMENT STUDIOS
The Harlem Globetrotters™ are THE originators of basketball style; captured by their dynamic athleticism, unique skill and historical influence on the modern game of basketball. Since 1926, the Globetrotters, proud members of the Naismith Memorial Basketball Hall of Fame, have used their legendary global tour to showcase their iconic brand of basketball to tens of millions in over 124 countries and territories across six continents.
They have expanded the brand by coming back to network television for the first time in 40 years with their Emmy nominated NBC series “Harlem Globetrotters: Play it Forward” which also airs onTelemundo as “Harlem Globetrotters: Ganando Con La Comunidad.” Content partners include Hidden Pictures, Atmosphere TV, and Hearts Media Production Group; consumer partnerships include, Sprayground, Undercrwn, Macys, Hybrid; and additional partnerships include our official tour partner Jersey Mikes, official ball partner, Spalding, Viral Nation, Hoopculture, and Citi.
Coined by the U.S. State Department in 1951 as Ambassadors of Goodwill, the team leverages their moniker to drive its Corporate Social Responsibility (CSR) efforts around their strategic pillars of Health & Wellness, Education, and Community Empowerment. These efforts have yielded partnership with the likes of Microsoft, U.S. State Department Sports Diplomacy, The National Archives, ‘Great Assist’ in partnership with Jersey Mike’s Subs, Campus Multimedia Court of Creativity, and Comic Relief Red Nose Day.
For more information about the Harlem Globetrotters™ and the Tour, visit the Globetrotters' official website: www.harlemglobetrotters.com. The Harlem Globetrotters™ is a subsidiary of Herschend, the largest family-owned themed attractions company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240916952134/en/
Contacts
Harlem Globetrotters Contact:
Mirian Arias / mirian.arias@harlemglobetrotters.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom